performance.io Drives Global Expansion with Apiary Capital Investment
Deal News | May 12, 2025 | Apiary Capital
Apiary Capital, a private equity firm, has successfully executed a major investment in performance.io (PIO), a specialist in digital performance marketing tailored for the pharmaceutical industry. This capital infusion is set to facilitate PIO's strategic growth and scaling plans, including accelerating its expansion into lucrative markets such as the US and Asia. The investment will also bolster the company's capabilities by allowing further investments in human resources and technological infrastructure. Founded by Matt Lowe, PIO has positioned itself as a leader in harnessing digital marketing strategies to drive increased web traffic and boost engagement among patients and healthcare professionals, specifically benefiting large pharmaceutical manufacturers. With digital marketing in the pharmaceutical sector still in developmental stages compared to other industries, this partnership aims to enhance PIO's innovative edge and market reach.
Sectors
- Digital Performance Marketing
- Pharmaceutical
Geography
- United States – The investment aims to support performance.io's expansion into the U.S. market.
- Asia – The strategic expansion plan for performance.io includes penetrating markets in Asia, as facilitated by Apiary Capital's investment.
Industry
- Digital Performance Marketing – The article discusses Apiary Capital's investment in performance.io, a company specializing in digital performance marketing services for the pharmaceutical sector, emphasizing the industry-specific focus on enhancing marketing strategies for large pharma manufacturers.
- Pharmaceutical – performance.io caters to the pharmaceutical industry by providing marketing services that optimize digital outreach and engagement, representing the sector in which the company primarily operates.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Apiary Capital | Investor | Company | A private equity firm that has invested in performance.io to support its expansion and scaling efforts. |
| performance.io (PIO) | Target Company | Company | A specialist provider of digital performance marketing services for the pharmaceutical industry, focusing on increasing web traffic and engagement. |
| Matt Lowe | CEO | Person | Founder and CEO of performance.io, leading the company's strategic direction and growth initiatives. |